|
MabVax Therapeutics Holdings, Inc. Provides Corporate Update and Reports …
MarketWatch … including a $17.9 million deemed dividend (non-cash) representing the difference in fair value of the common stock and common stock equivalents issued compared with the fair value of the Series A-1 and B preferred stock and related warrants eliminated. |
